RARE

Ultragenyx Pharmaceutical Inc. $16.78 as of 2026-10-29
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+1.4%
Next 1 month
+3.6%
Seasonality
Mildly negative window
Next 30 days (to Nov 29): -1.0% median, 45% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 51
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.05%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.28 +3.7% · Seasonal tilt (11y) -0.1%
$53M/day volume 82% volatility -52% 1-year
52-week range · 15% of the way up · -58% from the high
$12.73$39.89

Congressional trades in RARE Full tracker →

1 member · 5 buys / 0 sells · $5K–$75K disclosed · latest filing Oct 12, 2026.

BUY GC Gilbert Cisneros · traded Sep 29, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Feb 18, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Aug 8, 2025 $1K–$15K
BUY GC Gilbert Cisneros · traded Jul 15, 2025 $1K–$15K

Earnings Full history →

Next report 2026-11-03 (Tuesday, after close, in 4 days) · EPS est. -0.75.

1-day std dev
5.6%
Finished up
39%
Biggest pop
+14.3%
Biggest drop
-13.4%

Standard deviation of the close-to-close move over the last 51 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-04 beat -1.00 -0.90 +9.7% +10.3% -3.4% +4.1%
2026-05-05 miss -1.46 -1.54 -5.7% +3.6% +3.7% +5.8%
2026-02-12 miss -1.17 -1.29 -10.1% -8.3% -12.7% -4.2%
2025-11-04 miss -1.21 -1.81 -49.7% -11.0% -1.8% +3.3%
2025-08-05 beat -1.32 -1.17 +11.4% -1.5% -3.0% +0.2%
2025-05-06 beat -1.64 -1.57 +4.4% +1.7% -4.7% -1.0%
2025-02-13 miss -1.27 -1.39 -9.4% +2.3% -2.4% -3.9%
2024-11-05 beat -1.47 -1.40 +5.0% +0.7% -3.2% -6.7%
2024-08-01 beat -1.63 -1.52 +6.9% +6.9% +14.3% +13.3%
2024-05-02 miss -1.72 -2.03 -18.0% +3.9% -1.0% -5.3%
2024-02-15 beat -1.61 -1.52 +5.7% +1.6% +5.8% +8.6%
2023-11-02 miss -2.01 -2.23 -10.7% +0.5% +6.1% -4.7%
2023-08-03 miss -2.02 -2.25 -11.6% -0.5% -8.8% -12.1%
2023-05-04 miss -1.61 -2.33 -44.5% -4.0% +3.1% +2.8%
2023-02-16 miss -1.80 -2.19 -21.4% +7.5% +10.0% -1.8%
2022-11-02 miss -2.40 -3.48 -44.8% +0.2% -6.0% -7.4%
2022-07-28 miss -1.64 -2.12 -29.2% -0.7% +2.7% +7.2%
2022-05-05 miss -1.78 -2.06 -15.9% -4.4% -13.4% -22.5%
2022-02-10 miss -1.19 -1.55 -30.4% +10.0% +2.1% -6.6%
2021-11-02 miss -1.10 -1.45 -32.5% +2.7% +1.4% -5.5%
2021-08-02 miss -1.05 -1.35 -28.6% -0.2% +3.6% +13.6%
2021-05-04 miss -1.29 -1.72 -33.8% +0.0% +4.1% +4.5%
2021-02-11 miss -1.14 -1.59 -39.4% -4.3% -7.7% -11.1%
2020-10-27 beat -1.06 -0.94 +11.3% -5.0% -2.5% +16.5%
2020-07-30 beat -1.72 -1.14 +33.9% +6.1% +0.7% +9.3%
2020-05-06 miss -1.68 -2.04 -21.8% +4.0% -4.7% -2.3%
2020-02-13 miss -1.53 -1.62 -5.6% +0.2% -2.8% -9.3%
2019-11-05 miss -1.55 -2.00 -28.5% -1.4% -5.9% -6.5%
2019-08-01 miss -1.59 -1.90 -19.0% -3.9% -7.9% +0.9%
2019-05-06 miss -1.67 -1.82 -9.2% -3.5% -7.0% -6.4%
2019-02-19 beat -1.87 -1.73 +7.3% +5.5% +6.5% +12.0%
2018-11-05 beat -1.99 -1.74 +12.7% +2.5% +2.6% -7.7%
2018-08-02 beat -2.13 -1.87 +12.2% +3.3% -9.8% -4.2%
2018-05-07 miss -0.87 -2.07 -138.2% -0.5% -0.3% +8.2%
2018-02-20 miss -1.99 -2.27 -14.3% -3.3% -3.9% -0.8%
2017-11-02 beat -1.87 -1.87 +0.2% -1.6% +2.7% -1.7%
2017-07-27 miss -1.71 -1.72 -0.4% -2.5% -1.1% -6.6%
2017-05-04 beat -1.71 -1.63 +4.5% +1.7% -0.2% -5.3%
2017-02-16 miss -1.73 -1.75 -1.1% +1.9% +0.1% +10.9%
2016-11-07 miss -1.57 -1.64 -4.3% -1.7% +4.5% +39.1%
2016-08-08 miss -1.44 -1.46 -1.4% +1.0% -0.6% +0.5%
2016-05-09 miss -1.24 -1.35 -8.9% -3.0% -1.3% -8.5%
2016-02-25 miss -1.15 -1.16 -1.6% -0.5% +2.4% +3.1%
2015-11-09 miss -0.86 -1.03 -19.5% -1.4% -4.8% -2.3%
2015-08-13 miss -0.65 -0.83 -26.8% -1.9% -1.6% -8.4%
2015-05-11 miss -0.56 -0.63 -12.5% +0.1% +7.5% +24.0%
2015-03-25 beat -0.52 -0.52 +0.5% -0.7% -4.3% +9.8%
2014-11-10 miss -0.47 -0.50 -5.6% -0.6% +4.1% +8.3%
2014-08-11 -0.45 -0.45 — +0.7% -0.7% +13.2%
2014-05-12 miss -0.35 -0.84 -140.0% +0.1% -6.9% -7.5%
2014-03-24 miss -0.39 -4.98 -1176.9% +0.5% -6.6% -11.2%

Not investment advice.